ETFIQData as of Nov 18, 2026. · etfiq.com/funds/iqsm

IQSM Fact Sheet: NYLIM Candriam U.S. Mid Cap Equity ETF

Share
$38.63
close, Nov 18, 2026

Over the year to Nov 18, 2026, IQSM returned +17.6% in total and charged 0.15% a year.

1-year total return
+17.6%
IWV +12.0% to Nov 18, 2026
Expense ratio
0.15%
a year
Net flow, 12 months to Jul 31, 2026
+$72.5m
monthly N-PORT basis to Jul 31, 2026

Growth of $10,000, 1 year

IQSM $11,760 +17.6% · IWV $11,199 +12.0% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+0.7%
3 months−5.2%
Year to date+12.4%
1 year+17.6%
3 years+48.6%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
REVOLUTION MEDICINES INC1.32%
TWILIO INC1.01%
NVENT ELECTRIC PLC0.93%
BURLINGTON STORES INC0.93%
US FOODS HOLDING CORP0.92%
OKTA INC0.90%
F5 INC0.88%
GUARDANT HEALTH INC0.83%
VIATRIS INC0.78%
MKS INC0.76%

IQSM top ten by weight, 9.2% of the fund, of its 246 equity positions, from the holdings filed for Jul 31, 2026.

Facts

Equity fund · Tracks the NYLI Candriam U.S. Mid Cap Equity Index · First traded Oct 25, 2022 · Benchmark Russell 3000 Index, measured by IWV, which tracks the same index

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, IQSM Fact Sheet: NYLIM Candriam U.S. Mid Cap Equity ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/iqsm/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/iqsm.